#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16004	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2166	735.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1506	1506	C	933	C	856	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29316	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3427	851.3	0	.	n	.	0	T695C	SNP	695	695	T	993	993	C	872	C,T	813,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29316	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3427	851.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1635	1635	A	1003	A,G	937,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29316	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3427	851.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2269	2269	C	913	C	843	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29316	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3427	851.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2343	2343	A	949	A	894	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29316	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3427	851.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2895	2895	C	919	C,A	851,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	1954	folP	852	852	100.0	folP.l15.c4.ctg.1	1513	128.4	1	SNP	p	R228S	1	.	.	682	684	AGC	976	978	AGC	215;217;214	A;G;C	204;208;200	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4918	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3335	146.7	1	SNP	p	S91F	0	.	.	271	273	TCC	596	598	TCC	165;166;165	T;C;C	152;153;150	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4918	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3335	146.7	1	SNP	p	D95G	0	.	.	283	285	GAC	608	610	GAC	156;157;159	G;A;C	145;146;147	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4918	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3335	146.7	1	SNP	p	D95N	0	.	.	283	285	GAC	608	610	GAC	156;157;159	G;A;C	145;146;147	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1196	mtrR	633	633	97.47	mtrR.l15.c30.ctg.1	1207	98.6	0	.	p	.	0	D79N	NONSYN	235	237	GAT	527	529	AAT	170;173;175	A,G;A;T	160,1;162;164	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1196	mtrR	633	633	97.47	mtrR.l15.c30.ctg.1	1207	98.6	0	.	p	.	0	A86T	NONSYN	256	258	GCG	548	550	ACG	184;184;185	A,T;C;G	167,1;168;168	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1196	mtrR	633	633	97.47	mtrR.l15.c30.ctg.1	1207	98.6	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	605	607	CAC	186;185;182	C;A;C	173;168;169	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1196	mtrR	633	633	97.47	mtrR.l15.c30.ctg.1	1207	98.6	0	.	p	.	0	S183N	NONSYN	547	549	AGT	839	841	AAT	66;66;65	A;A,G;T	64;63,1;61	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1196	mtrR	633	633	97.47	mtrR.l15.c30.ctg.1	1207	98.6	0	.	p	.	0	M197I	NONSYN	589	591	ATG	881	883	ATA	59;60;59	A;T;A,G	58;57;56,1	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1196	mtrR	633	633	97.47	mtrR.l15.c30.ctg.1	1207	98.6	1	SNP	p	G45D	0	.	.	133	135	GGC	425	427	GGC	206;205;202	G;G;C	191;190;185	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5376	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3072	174.4	1	SNP	p	D86N	0	.	.	256	258	GAC	704	706	GAC	203;203;201	G;A;C	191;190;191	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5376	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3072	174.4	1	SNP	p	S87I	0	.	.	259	261	AGT	707	709	AGT	201;201;202	A;G;T	191;190;191	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5376	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3072	174.4	1	SNP	p	S87R	0	.	.	259	261	AGT	707	709	AGT	201;201;202	A;G;T	191;190;191	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5376	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3072	174.4	1	SNP	p	S87W	0	.	.	259	261	AGT	707	709	AGT	201;201;202	A;G;T	191;190;191	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5376	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3072	174.4	1	SNP	p	S88P	0	.	.	262	264	TCC	710	712	TCC	202;200;199	T;C,G;C	191;188,1;191	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4196	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2661	156.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1583	1585	GGC	209;206;206	G;G;C	196;191;186	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4150	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2349	175.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1291	1293	GCA	215;215;215	G;C;A	199;204;206	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4150	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2349	175.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1294	1296	ATC	218;217;219	A;T;C	207;206;206	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4150	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2349	175.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1306	1308	GTG	230;228;224	G;T;G	218;215;211	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4150	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2349	175.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1306	1308	GTG	230;228;224	G;T;G	218;215;211	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4150	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2349	175.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1810	1812	ACC	190;190;189	A;C;C	174;175;176	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4150	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2349	175.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1864	1866	GCG	178;179;179	G;C;G,C	160;149;148,1	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4150	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2349	175.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1864	1866	GCG	178;179;179	G;C;G,C	160;149;148,1	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4150	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2349	175.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1987	1989	GGC	174;174;173	G;G;C	159;156;160	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4150	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2349	175.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1996	1998	GGC	169;167;167	G;G;C	154;152;149	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4150	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2349	175.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2014	2016	CCG	149;152;153	C,G;C;GCCC,GGCCCC	111,7;113;111,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5798	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3061	188.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2154	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1655	129.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	486	486	C	149	C	135	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3064	porB1b	1038	1038	98.29	porB1b.l15.c4.ctg.1	1636	186.2	0	.	p	.	0	I45V	NONSYN	133	135	ATT	521	523	GTT	230;226;227	G;T;T	217;210;211	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3064	porB1b	1038	1038	98.29	porB1b.l15.c4.ctg.1	1636	186.2	0	.	p	.	0	I75V	NONSYN	223	225	ATT	611	613	GTT	236;237;236	G;T;T	217;207;213	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3064	porB1b	1038	1038	98.29	porB1b.l15.c4.ctg.1	1636	186.2	0	.	p	.	0	S89T	NONSYN	265	267	AGC	653	655	ACC	237;237;237	A;C,T;C	205;212,1;214	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3064	porB1b	1038	1038	98.29	porB1b.l15.c4.ctg.1	1636	186.2	0	.	p	.	0	I98V	NONSYN	292	294	ATC	680	682	GTC	240;240;240	G;T;C	222;214;221	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3064	porB1b	1038	1038	98.29	porB1b.l15.c4.ctg.1	1636	186.2	0	.	p	.	0	Y213_N214insRYAY	INS	637	637	T	1025	1025	T	262	T	247	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3064	porB1b	1038	1038	98.29	porB1b.l15.c4.ctg.1	1636	186.2	0	.	p	.	0	R272H	NONSYN	814	816	CGT	1214	1216	CAT	245;244;247	C;A;T	229;228;226	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3064	porB1b	1038	1038	98.29	porB1b.l15.c4.ctg.1	1636	186.2	1	SNP	p	G120K	1	.	.	358	360	AAG	746	748	AAG	242;242;243	A;A;G,A	228;228;225,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3064	porB1b	1038	1038	98.29	porB1b.l15.c4.ctg.1	1636	186.2	1	SNP	p	A121N	1	.	.	361	363	AAC	749	751	AAC	242;242;244	A;A;C,A	225;226;228,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3064	porB1b	1038	1038	98.29	porB1b.l15.c4.ctg.1	1636	186.2	1	SNP	p	N121D	0	.	.	361	363	AAC	749	751	AAC	242;242;244	A;A;C,A	225;226;228,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12242	rpoB	4179	4179	100.0	rpoB.l6.c30.ctg.1	4760	256.0	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1906	1908	AAT	290;289;288	A;A,T;T,A	274;273,1;270,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1354	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	942	142.7	1	SNP	p	V57M	1	.	.	169	171	ATG	494	496	ATG	260;263;259	A;T;G	246;247;241	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
